OSTEOPATHIC BOARD CERTIFICATION

IMPORTANT NEWS Re: Allergy and Immunology OCC Recertification – The Pediatric and Adult Allergy and Immunology Conjoint Examination Committee will now offer the NBOME Longitudinal Assessment to Diplomates. For the 2024 examination year, Diplomates may choose to take the high stakes examination, or participate in Longitudinal Assessment (LA). The LA program for 2024 will launch in July and will be open to those Diplomates who hold certificates which will expire Dec. 31, 2024, and those who qualify under BOS policy.

Board Eligibility

A physician’s eligibility for AOA board certification begins upon completion of their specialty or subspecialty training program and ends on Dec. 31 of the following sixth year.

Board eligibility status will be automatically terminated in the following circumstances:

  • After completion of the board eligibility timeframe.
  • Upon denial of an appeal to extend the board eligibility timeframe for an individual.
  • Upon award of certification.

The following eligibility requirements must be met for AOA board certification:

  • You must be a graduate of a COCA-accredited college of osteopathic medicine and have completed an AOA or ACGME-accredited training program OR be a graduate of a LCME-accredited medical school and have completed an ACGME-accredited training program.
  • You must hold a valid, active license to practice medicine in a U.S. state, commonwealth, District of Columbia, or U.S. territory.
  • You must adhere to the AOA Code of Ethics.
  • You must follow the process as outlined by the board’s requirements and meet any specialty-specific requirements for board certification during the six-year board eligibility period.
  • You must pass all required certification exams.

Re-Entry into the Certification Process

A physician who has not obtained final certification at the end of six years of board eligibility may petition their primary board—Pediatrics or Internal Medicine—for re-entry into the certification process. Upon acceptance by the candidate’s primary board, the candidate must sit for the next available exam.

Right to Appeal

If a candidate feels that the actions of the American Osteopathic Conjoint Examination Committee on Adult and Pediatric Allergy and Immunology with regard to any part of the examination constitute unequal application of the regulations and requirements or standards, unwarranted discrimination, prejudice, unfairness or improper conduct of the examination, he or she has the right to appeal to the examination committee.

Appeals can be made in writing to the American Osteopathic Conjoint Examination Committee on Adult and Pediatric Allergy and Immunology. The appellant must submit the completed Appeal Request Form to the board within 30 days of receipt of notification of failure in the case of all written exams. Each appeal submitted on an Appeal Request Form will be considered by the AOBP and the AOBIM. A majority vote of the Board will determine whether the AOBP and the AOBIM accept or deny the appeal.

The AOBP and the AOBIM will not consider appeals based on examination content, sufficiency or accuracy of answers given to examination questions, scoring of the examination, scoring of answers to individual questions, and/or the determination of the minimum passing score.

Compliance With Federal Regulations

The conjoint complies with all applicable federal and state regulations, including:

  • Americans with Disabilities Act (ADA): The conjoint committee complies with requirements prohibiting discrimination and ensuring equal opportunity for persons with disabilities in employment, state and local government services, public accommodations, commercial facilities, and transportation, as well as regulations for Title II and Title III (and all subsequent regulations) as printed in the federal register.
  • Health Insurance Portability and Accountability Act (HIPAA): In compliance with the HIPAA Act of 1996 and any subsequent modifications, the conjoint committee ensures that individuals’ health information is properly protected, while allowing the flow of health information to provide and promote high quality health care.